Sagar Lonial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sagar lonial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sagar Lonial Today - Breaking & Trending Today

Lonial Spotlights CAR T-Cell and Off-the-Shelf Treatments in Multiple Myeloma

Sagar Lonial, MD, FACP, details how CAR T-cell therapies and off-the-shelf treatments are improving outcomes for patients with multiple myeloma. ....

Miami Beach , United States , Janssen Biotech Inc , Fdad Is Co Burst Edition , Department Of Hematology , Winship Cancer Institute , American Society Of Hematology , International Myeloma Society Meeting , International Congress On Hematologic Malignancies , Cancer At Emory University School Of Medicine , International Myeloma Society Annual Meeting , Sagar Lonial , Medical Oncology , Bernard Gray Family Chair , Emory University School , Winship Cancer , American Society , Annual Meeting , Annual International Myeloma Society , Annual International Congress , Hematologic Malignancies , Winter Hematology , Burst Edition , Myeloma Society Annual Meeting , Accessed January , Cart Cell Therapy ,

Lonial Reviews 2023 Highlights for Multiple Myeloma, Forecasts 2024 Research Interests

Sagar Lonial, MD, FACP, details additional agents of interest outside CAR T-cell therapies in multiple myeloma including the recently approved agents elranatamab and talquetamab. ....

Cancer At Emory University School Of Medicine , Department Of Hematology , Sagar Lonial , New England Journal , Medical Oncology , Bernard Gray Family Chair , Emory University School , Relapsed Refractory Multiple Myeloma , Cart Cell Therapies , Idecabtagene Vicleucel , Ciltacabtagene Autoleucel , Phase 3 Karmma Trial Nct03651128 , Phase 3 Cartitude 4 Trial Nct04181827 , Bispecifict Cell Engagers ,

Quad Regimen for High-Risk Myeloma Produces High Rates of Durable MRD Negativity

Two-thirds of transplant-eligible patients met endpoint with isatuximab/KRd ....

Nordrhein Westfalen , Charles Bankhead , Katjac Weisel , Winship Cancer Institute In Atlanta , German Multiple Myeloma Group , International Staging System , Emory University , University Medical Center Hamburg , University Medical Center Hamburg Eppendorf , Sagar Lonial , Winship Cancer Institute , Medpage Today , Clin Oncol ,

Survival on the Upswing in Multiple Myeloma

Hematologists are heralding a new era in multiple myeloma. Experts discuss how times have changed. ....

United States , Tom Brokaw , Stanley Katz , Rafael Fonseca , Jamesr Berenson , Steve Scalise , Los Angeles , National Cancer Institute , Winship Cancer Institute , American Society Of Hematology , Emory University , National Comprehensive Cancer Network , Caris Life Sciences , West Hollywood , Sagar Lonial , Winship Cancer , Mayo Clinic , Yale Medicine , Republican Congressman Steve Scalise , American Society , Targeted Oncology , Adaptive Biotechnologies , Binding Site , Millennium Takeda , Multiple Myeloma , Plasma Cell Myeloma ,

Dr Lonial on the Outcomes of the IKEMA Trial in Relapsed Multiple Myeloma

Sagar Lonial, MD, FACP, discusses the final overall survival analysis of the phase 3 IKEMA trial of isatuximab when combined with carfilzomib and dexamethasone in patients with relapsed multiple myeloma, highlighting the progression-free survival and OS outcomes. ....

International Myeloma Society Annual Meeting , Emory University School Of Medicine , Department Of Hematology , Winship Cancer Institute Of Emory University , Sagar Lonial , Medical Oncology , Winship Cancer Institute , Emory University , Bernard Gray Family Chair , Emory University School , Myeloma Society Annual , Onclive Tv , Multiple Myeloma , Phase 3 Ikema Trial , Isatuximab Irfc ,